Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cora Health vs Layla

Cora Health
Graded #81

Higher grade

vs+1.2999999999999972
Layla
Graded #103

Lower grade

The verdict

Cora Health takes it — 72.2/100 to 70.9/100, but only just.

Cora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates. Layla is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCora Health +7
73
66
Dose & formulationLayla +24
72
96
Clinical oversightCora Health +6
82
76
Labs & monitoringCora Health +2
54
52
FulfillmentCora Health +24
89
65
Contract termsEven
55
55
Cora Health · left barLayla · right bar

The numbers

MetricCora HealthLayla
WeighScore72.2/10070.9/100
GradeCC
Scorecard rank#81#103
Semaglutide$175/mo$237/mo (all doses, compounded)
Tirzepatide$225/mo$199/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Cora Health

Graded #81 · C

Strengths

  • Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
  • Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
  • LegitScript Certified (seal ID 49690100 in footer)
  • Flat per-tier pricing — no dose-escalation surcharge
  • Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

Where it loses points

  • Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
  • Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
  • Lowest advertised prices require 12-month commitment with no partial refunds
  • No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
  • Founder names and funding undisclosed on site
Layla

Graded #103 · C

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard